Viewing StudyNCT00329940



Ignite Creation Date: 2024-05-05 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00329940
Status: COMPLETED
Last Update Posted: 2017-02-24
First Post: 2006-05-23

Brief Title: Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
rheumatologic tolerance View
Letrozole View
breast cancer View
critical musculoskeletal View
postmenopausal View